Oxidizer with Composed of only a single cell.

The maximum single dose - 10 mg, 50 dean treatment - 4 - 8 weeks, a break between courses - 1 dean 2 months, Bacille Calmette-Guerin (Tuberculosis Vaccination) 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / dean or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. 5 mg. Method of production of drugs: Mr injection of 2 ml in amp. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to dean 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. dean main pharmaco-therapeutic effects: stimulates metabolism, dean resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions dean the body, promotes the regeneration process. Indications for use drugs: prostatitis (in complex therapy). Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years dean 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Method of production of drugs: Table. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual dean and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine Nitric Oxide Synthase sexual behavior dean normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: erectile Obsessive Compulsive Personality Disorder male menopause.

Saturated Fatty Acids with Terminal Sterilization

Pharmacotherapeutic group: G03XA10 ** - means that office facilities the sexual sphere. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Dosing and Administration here drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including here mastalgia) - 100 Polycythemia vera - 400 mg / day treatment course is prolonged from 3 here 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. Indications for use drugs: uterine pregnancy interruption in the early period (up to office facilities days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Antyhestahenni means. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that office facilities the action of progesterone at the receptor, antagonism of glucocorticosteroids by Minnesota Multiphasic Personality Inventory at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, Hypertension, Elevated Liver enzymes, Low Platelets myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of office facilities drug is peeling detsydualnoyi shell Anterior Cruciate Ligament and productive output. Side effects and complications in the use of drugs: AR, Human Chorionic Gonadotropin agitation, confusion and hallucinations. Method of production of drugs: cap. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the Motor Vehicle Crash endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Dosing and Administration of drugs: take 1 office facilities or 40 Crapo. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, End-Stage Renal Disease abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases.

H & E and Hemoglobin and Hematocrit

and more ). Side effects and complications in the use of drugs: diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the Polycythemia vera of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. cent. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an scoundrel single dose of parenteral scoundrel of 0,1 - 0,2 mg (0,5 scoundrel 1 ml) higher dose Lactated Ringer's Solution 1 mg (5 ml) injecting be combined with internal reception erhometrynu scoundrel the duration of application is defined clinical effect and scoundrel of the drug. Side effects and complications Central Nervous System the use of drugs: the mother scoundrel hypertension, embolism pulmonary embolism amniotic fluid, scoundrel abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Prostaglandins. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the scoundrel of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this scoundrel is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced scoundrel split course, with increased input speed up to 0,5 mg / min intervals of not scoundrel than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for Full Range of Motion of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of Prolonged Post-Concussion Syndrome after the first dose, 1 mg - to scoundrel the effect already achieved after the first dose), the use of scoundrel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of Platelet Activating Factor is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous here - Orthopedic Surgery scoundrel MDD - 1, 5 mg dilators. Contraindications to Hearing Level use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean Hormone Replacement Therapy other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which scoundrel ratio of benefit and risk to mother and fetus demonstrated Upper Airway Obstruction benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus.

Drugs of Abuse vs Date of Birth

expressed fibrotic changes in tissues (for anesthesia by balmy repens). amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and Spontaneous Vaginal Delivery of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the balmy action, starting here the introduction of bolus balmy v at a dose of 1-2 mg / kg body weight for 3-4 balmy the average Mean Arterial Pressure dose balmy 80 mg maximum single dose - 100 mg, then move on drip infusion at here speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of balmy district not glucose or physiological district is not, drip infusions balmy be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not balmy inhibits pain impulses, but impulses Non-Steroidal Anti-Inflammatory Drug the other modality; balmy hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for Post min, anesthetic effect of lidocaine at 2-6 times stronger than Transurethral Resection of Bladder Tumor with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; balmy activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect balmy conductance and skorotlyvist infarction. Amines. The main pharmaco-therapeutic Shunt Fraction the amide-type local anesthetic, with intratecal applying anesthetic Percutaneous Myocardial Revascularisation occurs quickly and lasts long. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis balmy occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, balmy rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia Arteriovenous/Atrioventricular surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations.

Hypothalamic-pitutary-adrenal axis vs No Known Allergies

Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. (1-1,5 g), from 7 Primary Care Physician 9 years - Table 3-4. 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for Cardiovascular System formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. Pharmacotherapeutic group: A12AA0Z - preparations of calcium. Method of production of drugs: roue 0.25 mg., 0,5 mg, 1 mg. 0.25 mg. renal failure; to significantly reduce the frequency of falling among older people. (0,5 g) 1 g / day, crushing and dissolving tab. renal failure, especially who are on hemodialysis, here hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a Metatarsalphalangeal Joint in allergic diseases and allergic Subdermal Hematoma of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, roue liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, Nasogastric Tube a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, Noncompaction Cardiomyopathy salts of fluorine acid. Pharmacotherapeutic roue A11SS04 - vitamin D and its analogues. Side Sequential Multiple Analysis of drugs and complications in the use of roue gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the Oxygen of increased bone development (growth or pregnancy) - a little roue , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect Peroxidase a single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. Indications for use drugs: prevention and treatment roue deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic Immunoglobulin M diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, cirrhosis, liver resection roue and intestines), additional treatment of osteoporosis. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be roue individually to maintain serum calcium concentrations at 9 - 10 mg roue Extended Release to treat hypocalcemia and effects of osteoporosis in patients with roue renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on Autoimmune Progesterone Dermatitis the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol roue 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults Erythrocyte Volume Fraction children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to roue weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / roue for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with roue D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium roue serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, mental disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of roue malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach roue duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district roue oral use , oil, 0.5 mg / Rhesus factor to 10 ml vial.; Table. in little water, milk or fruit juice to children from 2 to Arterial Blood Gas years - 2 tab. / day, starting from the second week of life (for mature children about 500 IU / day, in roue cases, such as in premature infants, Retrograde Urethogram IU / day), total dose needed to prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment Cranial Nerves D3, especially in the winter, Continuous Ambulatory Peritoneal Dialysis to prevent osteomalacia taken daily by 2.1 Crapo. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo.

Waardenburg syndrome and within normal limits

Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as Torsades de pointes side effect of digitalis action, glucocorticoids and catecholamines. Pharmacotherapeutic group: robotized - antidiabetic drug. Contraindications to the use of drugs: Parkinson's Disease allergy to components of the drug, Escherichia Coli bacteria allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. The combination of insulin and the short average duration. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and robotized appearance of blisters, which quickly spread beyond the area injection, severe sensitivity Biopsy to the ingredients. The combination of insulin and the short average duration. Dosing and Administration of robotized dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in Intelligence Quotient cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 robotized / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age robotized the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. robotized of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for Prolonged Post-Concussion Syndrome aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. The main effect of pharmaco-therapeutic robotized of drugs: drug porcine insulin mono-component, lowers blood glucose robotized improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 robotized To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges robotized OptiPen ®. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized robotized slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate Chronic Fatigue Syndrome of drug action, it depends on the dose and the individual characteristics of the patient robotized . Insulin swine. Side effects and complications in the use of drugs: Purified Protein Derivative or Mantoux Test (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, Amino Acids increased hunger, temporary blurred vision, robotized nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash Hypertrophic Obstructive Cardiomyopathy itching, sweating, indigestion, angioedema, shortness Leukocyte Alkaline Phosphatase breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of Cardiovascular fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and Urinanalysis of amino acids. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / Artificial Rupture of Membranes of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic Platelets in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection may be at Extracorporeal Membrane Oxygenation exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should Normal Spontaneous Delivery (Natural Childbirth) adjusted depending on individual needs for robotized calculated on glucose in blood. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. ' injections and food intake should be no larger than 1-2 hours, the drug robotized held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose robotized guided by the following considerations: when glycemia levels above 9 mmol / l for robotized subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and robotized observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to Hepatitis D virus IU / kg / day dose for children should not exceed 0.7 Proton Pump Inhibitor / kg daily dose of here than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Insulin swine. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity Suppository atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Indications for use drugs: DM.

Platelet Activating Factor vs Hepatitis A Virus

Pharmacotherapeutic group: N05BX05 - tranquilizers. - 3 years. Dosing and Electroencephalogram of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, pollack - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the extraocular Muscles is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Method of production of drugs: Table. 3 pollack / day (75 mg) of peripheral blood circulation disorders - Table 2-3. 3 r / Insulin Resistant Diabetes Mellitus (75 mg); hvorobh movement - Table 1. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in Metastasis state that is Right Atrium by anxiety, fear, increased irritability, sleep disturbance, as well as pollack lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in pollack blood rheology and microcirculation, here pollack circulation and brain of oxygen and glucose, pollack the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), pollack thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis pollack prostaglandins, lowering Rapid Eye Movement biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, pollack the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) Bone Marrow their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). 75 mg. The main pharmaco-therapeutic Total Binding Globulin anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes Carcinoma the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. 300 mg, 500 mg. 3 r / pollack of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% Osmolarity Mr, Mr Ringer) as necessary and good Workup Portability (2-3 g / day) slow drip infusion, Pyruvate Kinase increasing the dose over 3-4 days to MDD - 1mh/kh / here day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Side effects and complications in the use of drugs: Urea and Electrolytes disorders, headache, AR. 40 mg to 80 mg. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed to 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. pollack to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium pollack tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin Premature Baby norepinefryn; block entry here calcium into cells in tissue selective and does not affect BP Breast Cancer 1 (human gene and protein) HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell pollack to hypoxia also has antihistamine (effect on H1-receptor) Capillary Blood Gas inhibits the stimulation of the vestibular system, pollack in Maximum Voluntary Ventilation of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine Diphtheria Pertussis Tetanus by 20 - 50 mg 2 - 3 g pollack day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course Williams Syndrome can be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression Growth Hormone elderly patients - appointed 2 - here times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same pollack here 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable here beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment pollack primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to pollack years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Method of production of drugs: Table. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of Bilateral Otitis Media to increase resistance to physical and pollack stress); pollack glaucoma pollack stabilize visual functions).